This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory
clinical trial of branched chain amino acids (BCAA's) in the treatment of concussion. The aim
of the study is to determine whether, compared to placebo treatment, administration of
BCAA's, at one or more doses, after a concussion improves neurocognitive recovery at one or
more time-periods post concussion.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
Main Line Health Pennsylvania Department of Health The Dana Foundation University of Pennsylvania